Emergent BioSolutions | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 3.48B 714M 2025-07
ALKERMES USD 5.44B 790M 2025-03
Alnylam Pharmaceuticals USD 41.19B 6.06B 2025-07
Amarin USD 186M 14M 2025-03
ANI Pharmaceuticals USD 1.35B 90M 2025-07
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Exact Sciences USD 8.16B 2.24B 2025-03
Exelixis USD 12.67B 3.15B 2025-07
Glaxosmithkline USD 69.83B 14.22B 2024-12
Ionis Pharmaceuticals USD 4.8B 722M 2025-03
Ironwood Pharmaceuticals USD 709M 51M 2024-12
Lonza CHF 38.7B 3.28B 2024-12
Merck USD 225.87B 25.78B 2025-03
Moderna USD 10.96B 5.04B 2025-03
Myriad Genetics USD 810M 442M 2025-03
Pacira USD 1.15B 280M 2025-03
Pfizer USD 143.72B 6.63B 2025-03
PTC Therapeutics USD 4.02B 511M 2025-03
Sanofi EUR 125.84B 7.44B 2025-03
Sarepta Therapeutics USD 6.19B 5.59B 2025-03
United Therapeutics USD 13.89B 1.86B 2025-03



Emergent BioSolutions Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.